Literature DB >> 15382236

Relationship between chaperone activity and oligomeric size of recombinant human alphaA- and alphaB-crystallin: a tryptic digestion study.

S Saha1, K P Das.   

Abstract

Alpha-crystallin, the major eye lens protein, exists as a large oligomer of two subunits, alphaA- and alphaB-crystallin. The individual subunits assemble into the oligomer in vitro. It is generally believed that oligomerization is pre-requisite for chaperone function, although there is no hard data available on this subject. We therefore undertook a study using limited tryptic digestion as a tool for examining the relationship between oligomeric size and chaperone activity of recombinant alphaA- and alphaB-crystallin. We showed that tryptic digested fragments of both alphaA- and alphaB-crystallin much smaller than the original subunits retain considerable chaperone activity. Our results indicate that chaperone activity depends more on the sequence of the reduced peptide than on its oligomeric size. The results also suggest that the presence of the alpha-crystallin domain and hydrophobic clefts on the protein surface, which correlate poorly with oligomeric size, are important for chaperone function. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15382236     DOI: 10.1002/prot.20230

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  13 in total

1.  Alpha-crystallin assisted refolding of enzyme substrates: optimization of external parameters.

Authors:  A Biswas; K P Das
Journal:  Protein J       Date:  2007-06       Impact factor: 2.371

2.  Protein kinase catalytic subunit (PKAcat) from bovine lens: purification, characterization and phosphorylation of lens crystallins.

Authors:  Bhaswati Samanta; Subir Kumar Nagdas; Kalipada Das; Parimal Chandra Sen
Journal:  Mol Cell Biochem       Date:  2007-05-25       Impact factor: 3.396

3.  Unfolding and refolding of bovine alpha-crystallin in urea and its chaperone activity.

Authors:  S Saha; K P Das
Journal:  Protein J       Date:  2007-08       Impact factor: 2.371

4.  Acetylation of αA-crystallin in the human lens: effects on structure and chaperone function.

Authors:  Ram H Nagaraj; Rooban B Nahomi; Shilpa Shanthakumar; Mikhail Linetsky; Smitha Padmanabha; Nagarekha Pasupuleti; Benlian Wang; Puttur Santhoshkumar; Alok Kumar Panda; Ashis Biswas
Journal:  Biochim Biophys Acta       Date:  2011-11-18

5.  Identification of histidine residues involved in Zn(2+) binding to αA- and αB-crystallin by chemical modification and MALDI TOF mass spectrometry.

Authors:  Srabani Karmakar; K P Das
Journal:  Protein J       Date:  2012-10       Impact factor: 2.371

6.  Effect of site-directed mutagenesis of methylglyoxal-modifiable arginine residues on the structure and chaperone function of human alphaA-crystallin.

Authors:  Ashis Biswas; Antonia Miller; Tomoko Oya-Ito; Puttur Santhoshkumar; Manjunatha Bhat; Ram H Nagaraj
Journal:  Biochemistry       Date:  2006-04-11       Impact factor: 3.162

7.  Conserved F84 and P86 residues in alphaB-crystallin are essential to effectively prevent the aggregation of substrate proteins.

Authors:  Puttur Santhoshkumar; K Krishna Sharma
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

Review 8.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

9.  Hydroimidazolone modification of the conserved Arg12 in small heat shock proteins: studies on the structure and chaperone function using mutant mimics.

Authors:  Ram H Nagaraj; Alok Kumar Panda; Shilpa Shanthakumar; Puttur Santhoshkumar; NagaRekha Pasupuleti; Benlian Wang; Ashis Biswas
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

10.  Role of alphaBI5 and alphaBT162 residues in subunit interaction during oligomerization of alphaB-crystallin.

Authors:  Raju Murugesan; Puttur Santhoshkumar; K Krishna Sharma
Journal:  Mol Vis       Date:  2008-10-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.